← Scoopfeeds — Intelligent news, curated.
Biotech firm Odyssey raises $279 million in upsized US IPO
business

Biotech firm Odyssey raises $279 million in upsized US IPO

Investing.com · May 8, 2026, 1:24 AM · Also reported by 4 other sources

Biotech firm Odyssey raises $279 million in upsized US IPO

Read full story on Investing.com → More top stories

Also covered by

Bloomberg Markets Surveillance Firm Hawkeye 360 Jumps 30% After $416 Million IPO CoinDesk Kraken to buy stablecoin payments firm Reap in $600 million deal: Bloomberg Decrypt Kraken Parent Acquires Asian Stablecoin Firm Reap for $600 Million: Bloomberg Yahoo Finance Kraken Parent Acquires Asian Stablecoin Firm Reap for $600 Million: Bloomberg

More in business

Bloomberg Markets
Why Oil May Hit $90 in Truce or $150 in Escalation
Investing.com
Oportun Q1 2026 slides: profitability streak continues amid credit focus
Investing.com
Alta Equipment Q1 2026 presentation shows monthly ramp, revised guidance
Investing.com
ESCO Technologies Q2 2026 slides: 63% EPS growth, guidance raised
Investing.com
US judge rules humanities grant terminations by DOGE were unlawful, discriminatory
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop